SCHEMBL577217

SCHEMBL577217

CC#CCCC(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL576308 0.84
SCHEMBL9366458 0.82 PTPN7 (0.63)
SCHEMBL4972079 0.82 LMNA (0.53)
SCHEMBL5375334 0.80 PTPN7 (0.67)
SCHEMBL3626347 0.80 PTPN7 (0.67)
SCHEMBL28743000 0.80 PTPN7 (0.67)
SCHEMBL11045543 0.80 PTPN7 (0.67)
SCHEMBL2123036 0.80 PTPN7 (0.67)
SCHEMBL10404839 0.80 PTPN7 (0.67)
SCHEMBL26624468 0.80 PTPN7 (0.67)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 411 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-120136965-A Isolated polypeptide of targeted MPP8 protein and application thereof 苏州系统医学研究所 2025-06-13 CN claimed
US-11964938-B2 3-phenyl-4-hexynoic acid derivatives as GPR40 agonists CELON PHARMA S.A. (PL) 2024-04-23 US claimed
CN-113906015-B Novel crystalline forms of 3- (4- (benzyloxy) phenyl) hex-4-ynoic acid derivatives 现代药品株式会社 2024-03-01 CN claimed
WO-2022269439-A1 METHOD OF CONTROLLING BLOOD SUGAR LEVEL AND TREATMENT OF DIABETES AND RELATED CONDITIONS ILDONG PHARMACEUTICAL CO., LTD. (KR) 2022-12-29 WO claimed
US-20220409598-A1 METHOD OF CONTROLLING BLOOD SUGAR LEVEL AND TREATMENT OF DIABETES AND RELATED CONDITIONS ILDONG PHARMACEUTICAL CO., LTD. (KR) 2022-12-29 US claimed
EP-2688868-A1 METHOD FOR THE SYNTHESIS OF DHA Phenomenome Discoveries Inc. (CA) 2014-01-29 EP claimed
US-20140012024-A1 METHOD FOR THE SYNTHESIS OF DHA PHENOMENOME DISCOVERIES INC. (CA) 2014-01-09 US claimed
WO-2012126088-A1 METHOD FOR THE SYNTHESIS OF DHA PHENOMENOME DISCOVERIES INC. (CA) 2012-09-27 WO claimed
CN-1217922-C 2-Amino-2-alkyl-4-hexenoic and hexynoic acid derivatives as nitric oxide synthase inhibitors PHARMACIA CORP (US) 2005-09-07 CN claimed
CN-1474804-A 2-amino-2-alkyl-4-hexenoic and hexynoic acid derivatives useful as nitric oxide synthase inhibitors 2004-02-11 CN claimed
US-6479191-B1 COMPRISING A NON-AQUEOUS SOLVENT, AN ELECTROLYTE SALT DISSOLVED THEREIN AND AT LEAST ONE ALKYNE DERIVATIVE UBE INDUSTRIES, LTD. (JP) 2002-11-12 US claimed
US-12620622-B2 Compound including sulfur-containing heterocyclic cation and bis(oxolato)borate anion, electrolytic solution and electrochemical device including the same DAIKIN INDUSTRIES, LTD. (JP) 2026-05-05 US disclosed
EP-4662319-A2 PERSONALIZED CRISPR PROFILING FOR CANCER Integrate Bioscience LLC (US) 2025-12-17 EP disclosed
WO-2025228947-A1 BIFUNCTIONAL COMPOUNDS CAPABLE OF INDUCING DEGRADATION OF POLO-LIKE KINASE1 CROSSFIRE ONCOLOGY B.V. (NL) 2025-11-06 WO disclosed
EP-4131548-B1 NON-AQUEOUS ELECTROLYTE FOR BATTERY, PRECURSOR FOR LITHIUM SECONDARY BATTERY, METHOD FOR MANUFACTURING LITHIUM SECONDARY BATTERY, LITHIUM SECONDARY BATTERY, PHOSPHAZENE COMPOUND, AND ADDITIVE FOR BATTERY MITSUI CHEMICALS INC (JP) 2025-08-27 EP disclosed
US-4189431-A CYCLIZATION OF POLYENINE TO POLYCYCLIC COMPOUND HAVING CYCLOPENTANO RING The Board of Trustees of Leland Stanford Junior University (US) 1980-02-19 US disclosed
US-4129599-A A-Norsteroids THE BOARD OF TRUSTEES OF LELAND STANFORD JR. UNIVERSITY (US) 1978-12-12 US disclosed
US-4064185-A Olefinically unsaturated substituents at C-11 of steroid cyclization precursors THE BOARD OF TRUSTEES OF LELAND STANFORD JUNIOR UNIVERSITY (US) 1977-12-20 US disclosed
US-4055603-A HORMONES THE BOARD OF TRUSTEES OF LELAND STANFORD JUNIOR UNIVERSITY (US) 1977-10-25 US disclosed
US-4032579-A POLY-UNSATURATED HYDROXY-ALKYNYL CYCLOPENTENOL THE BOARD OF TRUSTEES OF LELAND STANFORD JUNIOR UNIVERSITY (US) 1977-06-28 US disclosed